APTO

Aptose Biosciences, Inc.
APTO

Overview Fund Activity
Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

49 hedge funds and large institutions have $14.7M invested in Aptose Biosciences, Inc. in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
10
Closed
4
Calls
$38K
Puts
$10K
Net Calls
+$28K
Net Calls Change
-$124K

Top Buyers

1
AC
1
Annandale Capital
Texas
$422K
2
CC
2
Carlson Capital
Texas
$1.2M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$296K
4
SPC
4
Sigma Planning Corp
Michigan
$535K
5
VF
5
Virtu Financial
New York
$20K

Top Sellers

1
SMH
1
Sanders Morris Harris
Texas
$395K
2
NCM
2
Nantahala Capital Management
Connecticut
$4.1M
3
Morgan Stanley
3
Morgan Stanley
New York
$460K
4
VC
4
Voss Capital
Texas
$357K
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
51
Citadel Advisors
Florida
– -$20K -60 Closed
PFGIA
52
Patriot Financial Group Insurance Agency
Massachusetts
– -$2K -7 Closed
CAPTRUST Financial Advisors
53
CAPTRUST Financial Advisors
North Carolina
– -$1K -4 Closed
1 2
3